Gitnux/Report 2026

Consumer Health Industry Statistics

From OTC access and affordability to quality and recalls, this page tracks what is driving consumer health behavior and spending, including $255B in 2023 OTC revenue and $420.2B in 2023 dietary supplement growth. It also maps the digital shift behind purchases with 23x telehealth adoption and 1.1 billion global consumer health app downloads alongside the tension between rising check the label habits and persistent quality red flags.
308Statistics
78Sources
12Sections
1Visuals
50mRead
November 11, 2026Updated
Consumer Health Industry Statistics
Lukas BauerWritten by Lukas Bauer·Edited by Sophie Moreland·Fact-checked by Jonathan Hale
Published ·Updated
How this report is researched
01Editorial Scope

An editor sets the topic, the inclusion criteria, and the evaluation framework before research starts.

02Source Research

AI search agents locate sources and extract each figure together with the document it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 31 days

01 Industry overview

The consumer health industry at a glance

Global consumer health spending reached $337.9 billion in 2025, with growth shifting toward supplements, sports nutrition, gut health, beauty-from-within and digital commerce.

$337.9B
Global consumer health sales, 2025
7.6%[66]
Global forecast CAGR, 2025–2030
$107B[67]
U.S. consumer health sales, 2025
23%[25]
Consumer health sales online, 2025
Market size
Euromonitor estimated global consumer health spending at $337.9 billion in 2025. In the United States, Circana reported a consumer healthcare market of $107 billion in 2025, up 3% year over year.[67]
Forecast & CAGR
Heimdall Insights forecasts the global consumer healthcare market to grow from $345 billion in 2025 to $498 billion in 2030, representing a 7.6% CAGR. A separate Technavio forecast cited by Research and Markets projects $205.3 billion of incremental growth during 2025–2030 at a 7.2% CAGR.[66][68]
Market share & regions
The Americas accounted for $139 billion of consumer health value sales in 2024, the largest regional share in GlobalData’s regional assessment. Haleon reported that emerging markets generated 53% of consumer health market growth in 2025, while Asia Pacific was identified by Euromonitor as the leading region for absolute value gains through 2030.[69][25]
Segmentation
In the Americas in 2024, over-the-counter healthcare represented 49.6% of value sales and vitamins and dietary supplements represented 36.7%. Euromonitor’s 2025 framework covers OTC products, vitamins and dietary supplements, consumer health formats and distribution channels including pharmacies, grocery, traditional retail and e-commerce.[69][48]
Key players & concentration
The Americas consumer health market was fragmented in 2024: the five largest companies held 24.9% of value sales, with Haleon leading at 5.2%. Haleon identifies Bayer, Church & Dwight, Colgate-Palmolive, Kenvue, Nestlé, Opella, Procter & Gamble, Reckitt and Unilever among the sector’s major competitors.[69][25]
Pricing
Private-label health products, including medications and vitamins, held 24% of U.S. sales in 2024, according to Circana data reported by the Associated Press. This indicates meaningful price competition between branded consumer health products and retailer-owned alternatives.[19]
Trends, drivers & challenges
Growth is being driven by demand for protein, sports nutrition, gut health, beauty-from-within, longevity and mental-health products. Key challenges include volatile demand, inflation and affordability pressures, tariffs and currency movements, supply-chain exposure, tighter scrutiny of health claims and the potential impact of GLP-1 medicines on weight-management products.[25]
Consumer behavior & competition
E-commerce accounted for 26% of global consumer health sales in Euromonitor’s 2025 assessment and recorded a five-year CAGR of 13%, compared with 6% growth for the total industry. Haleon reported that 23% of consumer health sales were made online in 2025, while pharmacies remained important sources of advice and product access.[25]
M&A
Portfolio restructuring remained active in 2025: Sanofi completed the sale of a controlling 50% stake in its consumer health business to Clayton, Dubilier & Rice, creating Opella as a standalone company. Kimberly-Clark agreed to acquire Kenvue in a transaction valued at $48.7 billion, creating a consumer brands company expected to generate about $32 billion in annual revenue.[25][19]
Regulation
In the United States, dietary supplements are regulated as foods rather than drugs, and FDA generally does not approve them for safety or effectiveness before marketing. FDA’s OTC Monograph Drug User Fee Amendments were reauthorized for fiscal years 2026–2030, while a final rule creating an additional-condition pathway for certain nonprescription drugs took effect on May 27, 2025.[43]
Latest news
The most significant recent corporate development is Kimberly-Clark’s proposed $48.7 billion acquisition of Kenvue, announced in November 2025. The transaction would combine major brands including Tylenol, Band-Aid and Listerine with Kimberly-Clark’s consumer portfolio and is expected to create a company with approximately $32 billion in annual revenue, subject to approvals.[19]

02 Ranking

Top 9 Companies in the Consumer Health Industry

The leading companies in the consumer health industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 11, 2026 · Next review December 11, 2026

Verdict

Procter & Gamble leads Gitnux's 2026 consumer health ranking with an Overall score of 9.4, with $12.456 billion in fiscal 2026 Health Care segment sales. STADA is the runner-up at 8.9, driven by €1.549 billion Consumer Healthcare segment sales in 2025.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in consumer OTC & VMS

    Procter & Gamble

    US

    Ranked #1 · 9.4 · Consumer OTC & VMS

    Why we picked it: Its Health Care segment combines oral care and feminine care scale with a 22.7% operating margin.

    See in ranking ↓Visit pg.com ↗

  2. #2 overall

    STADA

    DE

    Ranked #2 · 8.9 · Consumer OTC & VMS

    Why we picked it: Its European OTC medicines and VMS portfolio contributes 36% of group revenue in 2025.

    See in ranking ↓Visit stada.com ↗

  3. #3 overall

    Nestlé

    CH

    Ranked #3 · 8.8 · Consumer OTC & VMS

    Why we picked it: Its medical nutrition, VMS and health science mix shows -2% revenue growth and 14.2% margin.

    See in ranking ↓Visit nestle.com ↗

Pick 1 is the #1 company overall. No other segment places in the top 5, so picks 2 and 3 follow rank.

Full ranking

Sort by
Top 9 companies in the consumer health industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Procter & Gamble

Consumer OTC & VMS · US

9.4
2

STADA

Consumer OTC & VMS · DE

8.9
3

Nestlé

Consumer OTC & VMS · CH

8.8
4

Opella

Consumer OTC & VMS · FR

8.6
5

Bayer

Consumer OTC & VMS · DE

8.4
6

Church & Dwight

Personal care and consumer health products · US

8.3
7

Kimberly-Clark

Consumer health, personal care and active aging · US

8.2
8

Herbalife

Nutrition, supplements and weight management · US

8.0
9

Perrigo

Private-label and branded self-care products · IE

7.2

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 11, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Lukas Bauer. (2026, February 13). Top 9 companies in the consumer health industry. In Consumer Health Industry Statistics. Gitnux. https://gitnux.org/consumer-health-industry-statistics/#top-companies

report visual · Comparison

Revenue of the largest consumer health companies

Nestlé leads with $101.1B in annual revenue (group level, converted to USD).

Nestlé$101.1B
Procter & Gamble$87.0B
Bayer$49.2B
Kimberly-Clark$16.4B
Church & Dwight$6.2B
Opella$5.0B
source-verifiednestle.com · us.pg.com · bayer.com · investor.kimberly-clark.com · investor.churchdwight.com · opella.com2026

04 Statistics

Technology & Innovation

Consumer-facing AI experiences drive adoption outcomes: nearly 70% of U.S. healthcare consumers linked a poor AI experience to the deploying company in 2026.

AI in the consumer health industry

  • Nearly 70% of U.S. healthcare consumers tied a poor AI experience at least partly to the company deploying it in 2026.[1]
  • 23% of U.S. direct-to-consumer digital health companies used artificial intelligence or machine learning between 2011 and 2023.[2]
  • 65% of respondents across 16 countries said they had used AI for healthcare in 2025.[3]
  • Over 300 million people reportedly ask ChatGPT health and wellness questions each week in 2026.[4]
  • Seven in ten U.S. consumers used health technology monthly in 2025, including wearables, apps and patient portals.[5]
  • 84% of U.S. wellness-focused consumers used AI for health and wellness in 2026, compared with 29% of wellness-shy consumers.[4]

Digital Transformation in the healthcare services sector (sector benchmark)

  • Across U.S. non-federal acute care hospitals, 71% used predictive AI integrated into electronic health records in 2024.[6]
  • About 70% of surveyed healthcare executives said investing in technology platforms for digital tools and services would be important or very important in 2025.[7]
  • Across surveyed healthcare practitioners, 60% believed their organizations’ digital experiences met or exceeded customer needs in 2025.[8]
  • Among healthcare respondents to KPMG’s global technology survey, 49% were adopting DevSecOps approaches to adapt digital-transformation strategies.[9]
  • About 90% of surveyed global healthcare C-suite executives expected digital technology use to accelerate in 2025, including 50% anticipating a significant impact.[7]

Technology Adoption in the healthcare services sector (sector benchmark)

  • Across U.S. non-federal acute care hospitals, 99% enabled patients to view health information electronically in 2024.[6]
  • Across U.S. non-federal acute care hospitals, 92% enabled patients to securely message providers in 2024.[6]
  • Across U.S. non-federal acute care hospitals, 84% enabled patients to transmit health information to a third party electronically in 2024.[6]
  • Across U.S. non-federal acute care hospitals, 70% enabled patient access through applications using HL7 FHIR specifications in 2024.[6]
  • Across U.S. non-federal acute care hospitals, 81% enabled patient access through applications using application-programming-interface specifications in 2024.[6]
  • Across U.S. non-federal acute care hospitals, 96% enabled patients to download health information electronically in 2024.[6]

Cloud Computing in the healthcare services sector (sector benchmark)

  • Across surveyed healthcare organizations globally, 27% reported that cloud operations were well managed and integrated into overall IT strategy at the end of 2025.[10]
  • Across surveyed healthcare organizations globally, 31% had a formal cloud strategy and governance framework that was not yet integrated into IT strategy at the end of 2025.[10]
  • Across surveyed healthcare organizations globally, 18% had started adopting cloud services but lacked a comprehensive cloud strategy at the end of 2025.[10]
  • Across surveyed healthcare organizations globally, 15% reported that cloud adoption was fully integrated into business strategy at the end of 2025.[10]
  • Across surveyed healthcare organizations globally, 8% reported minimal cloud adoption without formal strategy or governance at the end of 2025.[10]

Big Data in the healthcare services sector (sector benchmark)

  • Across Brazilian healthcare facilities conducting Big Data analytics, 77% used in-house staff rather than external providers in 2024.[11]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 38% used geolocation data from mobile phones, wireless connections, or GPS in 2024.[11]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 65% used patient demographics, forms, or medical-record data in 2024.[11]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 48% used social-media data in 2024.[11]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 72% used data from smart devices or sensors in 2024.[11]

IoT in the healthcare services sector (sector benchmark)

  • Among Brazilian outpatient healthcare facilities with internet access, 3% used IoT in 2024.[12]
  • Among Brazilian inpatient healthcare facilities with up to 50 beds and internet access, 5% used IoT in 2024.[12]
  • Among Brazilian private healthcare facilities with internet access, 6% used IoT in 2024.[12]

05 Statistics

Data & Analytics

Data governance and quality constrain analytics execution: 50% of U.S. clinical data abstractors reported data inaccuracies hamper clinical registry efforts in 2024.

Business intelligence in the consumer health industry

  • STADA reported more than 300 million annual impressions from local hero websites in 2023.[13]
  • STADA reported 295 social-media accounts across major platforms in 2023.[13]
  • STADA operated more than 35 country marketing dashboards for KPI-based advertising optimisation in 2023.[13]
  • IQVIA’s consumer-health business-intelligence tracker covers 88 countries and OTC, personal-care and nutrition categories.[14]
  • STADA reported 547 advertising accounts across digital platforms in 2023.[13]

Data analytics in the consumer health industry

  • Sixty-two percent of surveyed US consumers said they would probably or definitely share personal health-related information with their health system when used to support health, in 2024.[4]
  • Eighteen percent of surveyed US consumers said they would probably or definitely share personal health-related information with Google when used to support health, in 2024.[4]
  • Approximately 30% of data generated globally comes from the healthcare industry, according to the cited industry estimate used in McKinsey’s consumer-health analysis.[4]
  • Eighteen percent of surveyed US consumers said they would probably or definitely share personal health-related information with Apple when used to support health, in 2024.[4]
  • Seventeen percent of surveyed US consumers said they would probably or definitely share personal health-related information with Amazon when used to support health, in 2024.[4]
  • Sixteen percent of surveyed US consumers said they would probably or definitely share personal health-related information with grocery retailers when used to support health, in 2024.[4]

Data Quality in the healthcare services sector (sector benchmark)

  • 50% of U.S. healthcare clinical data abstractors reported that data inaccuracies hamper clinical registry efforts in 2024.[15]
  • 40% of U.S. healthcare clinical data abstractors reported that incomplete data hampers clinical registry efforts in 2024.[15]
  • 75% of U.S. healthcare organizations represented in the survey predominantly used clinical registry data for quality and process improvement in 2024.[15]
  • 8% of U.S. healthcare organizations rated their provider data as excellent in 2022.[16]
  • 40% of U.S. healthcare clinical data abstractors reported that manual data entry hampers clinical registry efforts in 2024.[15]

Data Governance in the healthcare services sector (sector benchmark)

  • 39% of healthcare organizations reported having a formally chartered data-governance function in 2025.[16]
  • 10% of healthcare organizations managed data governance exclusively within IT in 2025.[16]
  • 77% of healthcare organizations reported that their governance functions met at least quarterly in 2025.[16]
  • 72% of healthcare organizations operated governance using approved policy and standards frameworks in 2025.[16]
  • 66% of healthcare organizations reported multidisciplinary representation in governance, including patient or consumer representatives, in 2025.[16]
  • 38% of healthcare organizations had formal data and information quality-management statements in 2025.[16]

KPIs in the consumer health industry

  • IQVIA’s tracker measures new-product share of category as a KPI across the top 20 OTC categories.[14]
  • STADA used more than 35 country marketing dashboards for local monitoring and KPI-based optimisation of advertising effectiveness in 2023.[13]
  • IQVIA’s tracker measures innovation price relative to category price as a consumer-health performance KPI across 88 countries.[14]
  • STADA managed 295 social-media accounts as measurable consumer-engagement channels in 2023.[13]
  • STADA managed 547 advertising accounts as measurable digital channels in 2023.[13]
  • STADA reported more than 300 million annual impressions from local hero websites as a digital-engagement metric in 2023.[13]

06 Statistics

Strategy & Growth

Sports nutrition and digestive categories contribute measurable value share: cough, cold and respiratory products held 23.0% of global OTC sales in MAT Q4 2024.

Growth in the consumer health industry

  • 7.6% was Haleon’s 2024 organic revenue growth in vitamins, minerals and supplements.[17]
  • 6.2% was global digestive-remedies value growth in MAT Q4 2024.[14]
  • 5.0% was Haleon’s total organic revenue growth in 2024.[17]
  • 5.5% was Haleon’s 2024 organic revenue growth in digestive health and other products.[17]
  • 6.4% was IQVIA’s forecast five-year CAGR for the global OTC market.[14]
  • 9.6% was Haleon’s 2024 organic revenue growth in oral health.[17]

Differentiation in the consumer health industry

  • 23.0% was the value share of cough, cold and respiratory products in global OTC sales in MAT Q4 2024.[14]
  • 11% was the combined sales share of the top five VMS manufacturers in 2023.[18]
  • $15.5 billion was Kenvue’s 2024 net sales from a portfolio including Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec and Nicorette.[17]
  • 15.6% was the value share of digestive remedies in global OTC sales in MAT Q4 2024.[14]
  • 7.9% was the value share of skin-treatment products in global OTC sales in MAT Q4 2024.[14]
  • 22% was the combined sales share of the top 20 VMS manufacturers in 2023.[18]

Mergers and acquisitions in the consumer health industry

  • $32 billion was the estimated annual revenue of the combined Kimberly-Clark and Kenvue consumer brands businesses.[19]
  • 80.1% of Kenvue common stock was exchanged by Johnson & Johnson shareholders during the 2023 separation.[17]
  • $1 billion was the value of Aytu BioPharma’s 2024 divestiture of its consumer health business.[17]
  • $4.5 billion was Perrigo’s agreed purchase price for Omega Pharma in 2014.[17]
  • $48.7 billion was the announced value of Kimberly-Clark’s 2025 acquisition of Kenvue.[19]
  • 630 million Haleon shares were sold by Pfizer in a 2024 public offering.[17]

Strategic partnerships in the consumer health industry

  • 10.4% of Kenvue’s outstanding common stock was sold in its 2023 IPO.[17]
  • $15.5 billion was Kenvue’s 2024 net sales after becoming fully independent from Johnson & Johnson in 2023.[17]
  • 61% of surveyed health-and-beauty consumers preferred buying from a brand’s retail store in 2024.[20]
  • $103 billion was U.S. consumer health care sales in 2024, creating a large market for retailer and healthcare-professional partnerships.[21]
  • 24% was Pfizer’s remaining Haleon ownership after its 2024 share sale.[17]
  • 89.6% of Kenvue’s outstanding common stock was retained by Johnson & Johnson after the 2023 IPO.[17]

07 Statistics

People & Workforce

Workforce signals point to sustained reskilling needs: 59 out of every 100 workers are expected to need training by 2030.

Hiring in the consumer health industry

  • CVS Health hired more than 115,000 employees year to date in 2024 and targeted 145,000 hires by year-end.[22]
  • Johnson & Johnson’s 2024 workforce comprised 34.5% employees in North America, 28.0% in EMEA, 20.0% in Latin America and 17.5% in Asia Pacific.[23]
  • 34% of healthcare hiring leaders reported hiring challenges in 2025, according to GoodTime’s healthcare hiring research.[24]
  • Johnson & Johnson reported approximately 139,800 employees worldwide at December 29, 2024.[23]
  • Haleon had 25,408 employees at December 31, 2023, including 13,516 men and 11,768 women.[25]

Employee retention in the consumer health industry

  • Haleon’s employee engagement rate rose to 82% in 2025 from 81% in 2024 and 78% in 2023.[25]
  • 57.4% of pharmacy-sector workers said professional development and upskilling would make them more likely to stay with an employer in 2025.[26]
  • CVS Health reported 27.3% voluntary employee turnover and 5.7% involuntary turnover in 2024.[18]
  • 46% of workers in Gallagher’s 2024 survey were actively considering changing jobs, up from 35% in 2022.[27]
  • 81.5% of pharmacy-sector workers said a positive work environment was essential to retaining them in 2025.[26]

Remote Work in the healthcare services sector (sector benchmark)

  • Across U.S. medical groups, 52% reported that 1%–25% of their workforce worked remotely at least 50% of the time.[28]
  • Across U.S. medical groups, 18% of leaders expected their organization’s share of remote or hybrid jobs to decrease during 2024.[28]
  • Across U.S. health care and social assistance, 18% of full-time employees worked fully from home during December 2024–March 2025.[29]
  • Across U.S. medical groups, 22% of leaders expected their organization’s share of remote or hybrid jobs to increase during 2024.[28]

Hybrid Work in the healthcare services sector (sector benchmark)

  • Across U.S. health care and social assistance, 24% of full-time employees were in hybrid arrangements during December 2024–March 2025.[29]
  • Across U.S. healthcare support roles, 14% had part-time remote availability, equivalent to hybrid availability, in the 2022 McKinsey American Opportunity Survey.[28]
  • Across U.S. healthcare practitioners and technical roles, 16% had part-time remote availability, equivalent to hybrid availability, in the 2022 McKinsey American Opportunity Survey.[28]
  • About 6% of U.S. healthcare jobs were hybrid in a 2024 Robert Half survey cited by the Medical Group Management Association.[28]
  • About 12% of nonclinical healthcare administrative and customer-support jobs were hybrid in a 2024 Robert Half survey cited by the Medical Group Management Association.[28]

Upskilling in the consumer health industry

  • 50% of workers globally had completed training, reskilling or upskilling measures in 2025, according to the World Economic Forum’s workforce analysis.[30]
  • 59 out of every 100 workers were expected to need training by 2030 in the World Economic Forum’s 2025 analysis.[30]
  • Haleon trained employees in responsible AI and practical AI use as part of its 2025 AI governance program.[25]
  • CVS Health employees completed approximately 16 million hours of learning and development courses in 2025.[17]
  • 57.4% of pharmacy-sector workers said professional development and upskilling increased their likelihood of staying in 2025.[26]

Employee Engagement in the healthcare services sector (sector benchmark)

  • Across U.S. healthcare organizations, employee turnover fell from 20% to 18% in 2024.[31]
  • Across 2.3 million U.S. healthcare workers, employee engagement declined by 0.02 points in 2024.[31]
  • Among U.S. healthcare advanced practice providers, 52% felt heard in 2024.[31]
  • U.S. registered nurses with low teamwork scores were 1.53 times more likely to leave their healthcare organization in 2024.[31]
  • Across NHS staff, the national staff-engagement theme score was 6.64 in the second quarter of 2024/25.[32]

DEI in the consumer health industry

  • Women represented 48% of Haleon executive-team direct reports in 2023.[25]

08 Statistics

Customer & Sales

Interaction design matters for retention and acquisition: 60% of U.S. healthcare consumers preferred human help over AI when both options were equally available in 2026.

Customer experience in the consumer health industry

  • 60% of US healthcare consumers preferred human help over AI when both options were equally available in 2026.[1]
  • 87% of US healthcare consumers said human connection during a high-stakes purchase was important or very important in 2026.[1]
  • 39% of US healthcare consumers said they were likely to stop doing business after one bad experience in 2026.[1]
  • 85% of US healthcare consumers said it mattered that a brand’s AI clearly identified itself as AI in 2026.[1]
  • 63% of US healthcare consumers had definitely or possibly spoken to an AI voice agent during a recent healthcare purchase journey in 2026.[1]

Customer retention in the consumer health industry

  • 64% of loyal health, beauty and wellness customers bought from their favorite brand every month in 2026.[33]
  • 24.4% of health, beauty and wellness consumers said rewards taking too long to earn or redeem was their top loyalty-program frustration in 2026.[33]
  • 16.66% of health, beauty and wellness consumers said generic or non-personalized offers frustrated them in loyalty programs in 2026.[33]
  • 69% of health, beauty and wellness brands reported an approximately 50/50 budget split between customer acquisition and retention in 2026.[33]
  • 67.3% of health, beauty and wellness consumers agreed that brands prioritize acquiring new customers over rewarding existing customers in 2026.[33]

Customer acquisition in the consumer health industry

  • 63% of US healthcare consumers had definitely or possibly encountered an AI voice agent during a healthcare purchase journey in 2026.[1]
  • 67.3% of health, beauty and wellness consumers believed brands prioritized new-customer acquisition over rewarding existing customers in 2026.[33]
  • 85% of US healthcare consumers said they would switch to a competitor if the competitor responded faster, making response speed a customer-acquisition factor in 2026.[1]
  • 84.1% of US consumers seeking medical information online used search engines in 2026.[34]
  • 65.1% of US consumers seeking medical information online started with search engines in 2026.[34]

Customer loyalty in the consumer health industry

  • 7.8% of health, beauty and wellness consumers belonged to no loyalty programs in 2026.[33]
  • 11.26% of health, beauty and wellness consumers cited personalized offers as their main loyalty driver in 2026.[33]
  • 34.36% of health, beauty and wellness consumers cited product quality as the main reason they stayed loyal to a brand in 2026.[33]
  • 17.7% of health, beauty and wellness consumers belonged to six or more loyalty programs in 2026.[33]
  • 37.5% of health, beauty and wellness consumers belonged to three to five loyalty programs in 2026.[33]

Lead generation in the consumer health industry

  • 65.1% of US online medical-information seekers started their search with a search engine in 2026.[34]
  • 29% of US healthcare consumers called during a purchase because required information was not available online in 2026.[1]
  • 84.1% of US online medical-information seekers used search engines, a principal discovery channel for healthcare leads, in 2026.[34]
  • 85% of US healthcare consumers said they would switch to a faster-responding competitor after submitting or making a healthcare inquiry in 2026.[1]
  • 93 million US adults recalled seeing healthcare advertisements on social media in the 2024 MARS Consumer Health Study.[35]

09 Statistics

Marketing & Brand

Digital discovery stays concentrated on search and social influence: 84.1% of U.S. online medical-information seekers used search engines in 2026.

Marketing in the consumer health industry

  • 58% of US consumers regularly used supplements and vitamins in 2024.[9]
  • 17% of US consumers regularly used meditation or mindfulness programs in 2024.[9]
  • 12% of US consumers regularly used online workout programs in 2024.[9]
  • 26% of US consumers regularly used fitness trackers or wearables in 2024.[9]
  • 46% of US consumers identified word of mouth as a top persuader for health and wellness brands in 2024.[36]

Digital marketing in the consumer health industry

  • 24 million US social-media users had refilled a prescription after seeing healthcare advertising in the 2024 MARS Consumer Health Study.[35]
  • 20% of consumers across 17 international markets said they were satisfied with their digital health experiences in 2023.[37]
  • 71% of US social-media users who saw healthcare advertising were more likely to visit a pharmaceutical company’s website in the 2024 MARS study.[35]
  • 23% of consumers across 17 international markets said they were satisfied with their digital health experiences in 2022.[37]
  • 54% of US social-media users who saw healthcare advertising often discussed new prescription medicines with their doctor in the 2024 MARS study.[35]

Branding in the consumer health industry

  • 69% of US consumers identified prior experience as important to trusting headache or pain-reliever brands in 2022.[38]
  • 63% of US consumers identified prior experience as important to trusting cold-and-flu-remedy brands in 2022.[38]
  • 64% of US consumers identified prior experience as important to trusting allergy-relief brands in 2022.[38]
  • 65% of US consumers identified prior experience as important to trusting cough-remedy brands in 2022.[38]
  • 67% of US consumers identified prior experience as important to trusting hair-care brands in 2022.[38]

Social media in the consumer health industry

  • 24 million US social-media users had refilled a prescription after seeing healthcare advertising in 2024.[35]
  • Nearly 40% of US social-media users with a chronic condition valued social-networking sites for healthcare information in 2024.[35]
  • One in two US social-media users with a chronic condition said pharmaceutical advertising made them more knowledgeable in 2024.[35]
  • More than half of US caregivers’ internet time was spent on social media in the 2024 MARS Consumer Health Study.[35]
  • 69% of US social-media users had a chronic condition in the 2024 MARS Consumer Health Study.[35]

Influencer Marketing in the healthcare services sector (sector benchmark)

  • 50% of U.S. physicians surveyed had changed prescribing choices based on healthcare influencer or KOL content on social media in 2024.[39]
  • 50% of healthcare and pharmaceutical marketers reported dedicated, growing creator/influencer budgets in 2026, compared with 58% globally.[40]
  • 38% of posts from U.S.-focused health and wellness influencers promoted a product, service or subscription in 2026.[41]
  • 92% of U.S.-focused health and wellness influencers included product or service promotions at least occasionally in 2026.[41]
  • 8.57 million influencer posts about the health industry generated a 1.07% average engagement rate globally in 2023.[42]

10 Statistics

Operations & Execution

Operating-model change shows up as cost and productivity targets: Kenvue targeted $350 million of annualized savings by 2026.

Process optimization in the consumer health industry

  • $550 million is Kenvue’s estimated total pretax cost for its 2024 multi-year restructuring initiative to optimize the company’s cost structure.[17]
  • 200 basis points was Kenvue’s year-over-year adjusted gross-profit-margin improvement in 2024, driven by productivity enhancements.[17]
  • $275 million was the approximate pretax restructuring expense Kenvue expected to incur in each of fiscal years 2024 and 2025.[17]
  • 20% more was invested in Kenvue brands in 2024 after efficiencies from its Our Vue Forward program were redirected to advertising and consumer engagement.[17]
  • $350 million of annualized savings by 2026 is the target of Kenvue’s two-year Our Vue Forward operating-model initiative.[17]

Operational efficiency in the consumer health industry

  • 1.5% was Kenvue’s 2024 organic-sales growth after its first full year operating as an independent consumer-health company.[17]
  • 8.5% was Prestige Consumer Healthcare’s 2024 international OTC revenue growth, reaching $167.1 million.[17]
  • $1.7 billion was Kenvue’s net cash flow from operating activities in 2024.[17]
  • $1.3 billion was Kenvue’s 2024 free cash flow, supported by operating-model and productivity improvements.[17]
  • $15.5 billion was Kenvue’s 2024 net sales as the world’s largest pure-play consumer-health company by revenue.[17]

Quality management in the consumer health industry

  • 2.6% of FDA pharmaceutical-quality surveillance findings in fiscal 2024 were classified under antineoplastics.[43]
  • 0.35% of other OTC products were recalled annually on average during fiscal years 2020–2024.[43]
  • 3.3% of FDA pharmaceutical-quality surveillance findings in fiscal 2024 were classified under gastrointestinal agents.[43]
  • More than 450 drug-recall events involving more than 1,900 OTC drug products occurred in the United States during fiscal years 2020–2024.[43]
  • 93% of manufacturers producing top store-brand OTC products also manufactured other OTC products during fiscal years 2020–2024.[43]

Supply chain in the consumer health industry

  • $151 million was Kenvue’s 2024 increase in Essential Health adjusted operating income, driven partly by supply-chain-optimization benefits.[17]
  • $72 million was Kenvue’s 2024 decrease in Skin Health and Beauty adjusted operating income amid volume and competitive pressures.[17]
  • $126 million was Kenvue’s 2024 decrease in Self Care adjusted operating income, partly reflecting volume-related sales decreases despite supply-chain benefits.[17]
  • $3.2 million was Prestige Consumer Healthcare’s international OTC foreign-currency headwind in fiscal 2024, affecting reported supply-chain and operating results.[17]
  • More than 50 countries were covered by Kenvue’s transition-service agreements during its separation into a standalone consumer-health company.[17]

Outsourcing / Offshoring in the healthcare services sector (sector benchmark)

  • 43% of global healthcare providers used third-party providers for payroll services in 2024, based on a survey of 28 healthcare-provider executives.[44]
  • 54% of global healthcare providers used third-party providers for supply-chain services in 2024, based on a survey of 28 healthcare-provider executives.[44]
  • 29% of global healthcare providers used third-party providers for remote patient monitoring in 2024, based on a survey of 28 healthcare-provider executives.[44]
  • 46% of global healthcare providers used third-party providers for customer-experience services in 2024, based on a survey of 28 healthcare-provider executives.[44]
  • 20% of U.S. medical-group leaders planned to outsource or automate some revenue-cycle-management activities in 2024, according to an MGMA poll with 262 responses.[28]

11 Statistics

Finance & Pricing

Price actions remain central: NIQ reported a 5.4% increase in Health Care prices globally for the latest 52 weeks ended June 15, 2025.

Pricing strategy in the consumer health industry

  • 55.2% was Prestige Consumer Healthcare’s North American OTC contribution margin in fiscal 2024 after pricing actions and product-mix effects.[45]
  • 5.4% was the increase in Health Care prices reported by NIQ globally for the latest 52 weeks ended June 15, 2025.[46]
  • 0.5% was Kenvue’s 2025 Essential Health organic-sales decline component attributed to favorable value realization after volume effects.[17]
  • Nearly 10% was the decrease in Health Care prices in Latin America reported by NIQ for the latest 52 weeks ended June 15, 2025.[46]
  • 3.9% was Kenvue’s favorable value realization across product categories in 2024, led by oral-care innovation and promotional strategies.[17]

Cost reduction in the consumer health industry

  • $60 million was the comparable transformation cost incurred in fiscal 2023 for the streamlined operating-model program.[17]
  • 200 basis points was Kenvue’s 2024 gross-profit-margin improvement associated with productivity enhancements and cost reduction.[17]
  • $350 million is Kenvue’s targeted annualized gross cost saving beginning in 2026 from its restructuring and operating-model initiatives.[17]
  • $32 million was the cost incurred by the company in fiscal 2024 for its streamlined operating-model program and related transformation work.[17]
  • $500 million-plus is the cost saving expected by CVS Health in 2025 from its enterprise-wide restructuring plan to streamline operations.[47]

Profitability in the consumer health industry

  • $1.14 was Kenvue’s adjusted diluted earnings per share in 2024.[17]
  • $1.0 billion was Kenvue’s 2024 net income.[17]
  • $2.2 billion was Kenvue’s 2024 adjusted net income.[17]
  • 21.5% was Kenvue’s adjusted operating-income margin in 2024.[17]
  • 60.4% was Kenvue’s adjusted gross-profit margin in 2024.[17]

Financial planning in the consumer health industry

  • $350 million of annualized savings by 2026 was Kenvue’s financial target for its Our Vue Forward initiative.[17]
  • $1.17 billion was the cash and cash equivalents Kenvue retained immediately after its 2023 initial public offering.[17]
  • $13.8 billion was distributed by Kenvue to Johnson & Johnson in connection with its 2023 separation and financing transactions.[17]
  • $1.3 billion was Kenvue’s 2024 free cash flow available to support investment and capital allocation.[17]
  • $275 million was Kenvue’s planned pretax restructuring expense for fiscal 2024.[17]

12 Statistics

Product & Service

Product development in the consumer health industry

  • Eighty-two percent of surveyed consumers intended to purchase at least one product in nutrition, supplements or personal care, globally, in 2026.[5]
  • In the most innovative over-the-counter category, five of the ten leading companies obtain more than 30% of sales from new launches and brands, globally.[14]
  • Freshness Index values range from 6% to 18% across the top 20 over-the-counter categories, measuring sales from innovation, globally.[14]
  • Over 85% of vitamins-and-dietary-supplements new product developments were sub-brand launches across 2021–2023, globally.[48]
  • Fifty-five percent of surveyed consumers intended to purchase health devices, equipment or smart environments, globally, in 2026.[5]

Product lifecycle in the consumer health industry

  • IQVIA’s consumer-health innovation tracker measures the contribution of innovation to parent-brand growth or share across the top 20 OTC categories.[14]
  • The US consumer-health market was projected at $87 billion in 2023 across OTC, sports nutrition and vitamins-and-dietary-supplements categories.[9]
  • IQVIA’s tracker covers new-product, line-extension, price and volume growth drivers for consumer-health products across 88 countries.[14]
  • IQVIA’s consumer-health innovation tracker evaluates launches based on sales during the last three years, across 88 countries.[14]
  • The US consumer-health market was projected to grow at a 1.2% compound annual rate from 2023 to 2028.[9]

After-sales in the consumer health industry

  • Sixty percent of surveyed North American homeowners rated their post-purchase experiences with manufacturers as underwhelming, in 2017.[49]
  • Fifty-six percent of surveyed North American homeowners were disappointed with service from retailers and e-commerce sites after purchase, in 2017.[49]
  • Only 17% of surveyed North American consumers considered manufacturers and retailers extremely good at caring for customers after a sale, in 2017.[49]

Value proposition in the consumer health industry

  • Thirty percent of US supplement users cited immune health as a reason for taking supplements in 2024.[50]
  • Twenty-seven percent of US supplement users cited energy as a reason for taking supplements in 2024.[50]
  • Forty-two percent of US supplement users cited overall health and wellness as their reason for taking supplements in 2024.[50]
  • Seventy-four percent of Hispanic consumers surveyed preferred functional foods or holistic supplements over prescription or over-the-counter medicines, in the 2023 US consumer report.[51]
  • Seventy-five percent of US adults reported using dietary supplements in the 2024 Consumer Survey, conducted for the consumer-health supplement industry.[50]

13 Statistics

Sustainability & Ethics

Packaging and water stewardship appear as measurable requirements: all 24 Haleon manufacturing sites were certified to the Alliance for Water Stewardship Standard in 2025.

Sustainability in the consumer health industry

  • All 24 Haleon manufacturing sites were certified to the Alliance for Water Stewardship Standard in 2025.[25]
  • P&G reported 80% of consumer packaging designed to be recyclable or reusable in fiscal 2024.[52]
  • 90% of Haleon’s key materials were sustainably sourced and deforestation-free in 2025.[25]
  • 69% of Kenvue packaging was recyclable or refillable across its portfolios in 2024.[53]
  • 80% of Haleon’s packaging was recycle-ready globally in 2025.[25]

ESG in the consumer health industry

  • Haleon’s employee engagement score was 82% in 2025.[25]
  • Haleon received CDP scores of B for climate change, B for forests and A- for water security in 2025.[25]
  • Haleon maintained ISS ESG Prime status with a C+ rating in June 2025.[25]
  • Haleon scored 72 out of 100 in the S&P 2024 Global Corporate Sustainability Assessment, reported in February 2025.[25]
  • Haleon’s women-in-leadership representation was 46.8% globally excluding the United States and Puerto Rico in 2025.[25]

Ethics in the consumer health industry

  • 53% of Reckitt’s investigated Speak Up cases in 2022 were substantiated or partially substantiated.[54]
  • 50% of the 11,947 third parties assessed by Reckitt in 2022 received screening for anti-bribery, sanctions, competition-law and human-rights risks.[54]
  • Reckitt assessed 11,947 third parties through its ethics and compliance process in 2022.[54]
  • Reckitt received 624 Speak Up reports in 2022, of which 417 cases merited investigation.[54]
  • Reckitt conducted in-depth investigations on 430 third parties in 2022, equal to 7% of those assessed.[54]

CSR in the consumer health industry

  • Haleon’s Health Partner Programme empowered more than 52 million people in 2025.[25]
  • Kenvue provided more than $50 million in in-kind donations in 2025.[53]
  • Kenvue donated more than 110,000 products from brands including Neutrogena, Listerine, OGX and Johnson’s Baby in 2025.[53]
  • Haleon’s Theraflu health-inclusivity programme empowered more than 10 million people in 2025.[25]
  • Kenvue distributed more than 22,000 hygiene kits to underserved communities in 2025.[53]

Circular economy in the consumer health industry

  • P&G used 116,000 metric tons of recycled plastic resin in fiscal 2023–24.[52]
  • Kenvue reduced virgin plastic in packaging by 21.4% against its 2020 base year in 2024.[53]
  • P&G reduced virgin petroleum plastic in consumer packaging by 21% per unit of production against its 2017 baseline in fiscal 2024.[52]
  • 17% of P&G’s total packaging resin came from recycled sources in fiscal 2023–24.[52]
  • P&G recycled or reused 99.6% of manufacturing waste in 2024.[52]

Carbon footprint in the consumer health industry

  • Haleon reported 20 thousand tonnes of emissions offset globally in the 2025 reporting period.[25]
  • Haleon reported 57 thousand tonnes of global Scope 1 greenhouse-gas emissions in the 2025 reporting period.[25]
  • Haleon reported 43 thousand tonnes of net market-based Scope 1 and 2 emissions globally in the 2025 reporting period.[25]
  • Haleon reported 63 thousand tonnes of market-based Scope 1 and 2 emissions globally in the 2025 reporting period.[25]
  • Haleon reported 6 thousand tonnes of market-based Scope 2 emissions globally in the 2025 reporting period.[25]

15 Statistics

Globalization & Expansion

Market geography drives absolute gains: Asia Pacific was identified by Euromonitor as the leading region for absolute value gains through 2030.

Globalization in the consumer health industry

  • $357.1 billion was the estimated global consumer health market size in 2025.[61]
  • $15.5 billion was Kenvue’s net sales in fiscal 2024, generated across North America, APAC, EMEA and Latin America.[17]
  • 120 markets were served by Haleon’s consumer health business in 2020.[17]

Cultural adaptation in the consumer health industry

  • 51.0% was the pharmacy share of Spain’s consumer health channels in 2022.[62]
  • 45% of retail value sales in Asia-Pacific consumer health came from health and beauty specialists in 2024.[63]
  • 13.7% was the grocery-retailer share of Spain’s consumer health channels in 2022.[62]
  • 20.9% was the direct-selling share of Spain’s consumer health channels in 2022.[62]
  • 38% was China’s pharmacy share of consumer health in 2023.[63]

Supplier management in the consumer health industry

  • $27.1 million of Perrigo’s 2024 gross-profit performance came from new products.[17]
  • $1 million was Kenvue’s separation-related cost of sales in 2024.[17]
  • $129.3 million was Perrigo’s decrease in gross profit in 2024.[17]
  • 630 million Haleon shares were sold by Pfizer in a March 2024 public offering.[17]
  • $235 million was Haleon’s 2023 sale price for the Lamisil antifungal brand.[17]

Stakeholder management in the consumer health industry

  • 10.4% of Kenvue’s outstanding common stock was offered in its May 2023 IPO.[17]
  • 24% was Pfizer’s Haleon ownership after reducing its stake in 2024.[17]
  • 4.5 million people had been reached by Johnson & Johnson’s U.S. community-health efforts since 2020.[64]
  • 2.4% was total U.S. multi-outlet retail growth in 2024, compared with 4% consumer health care growth.[21]
  • 89.6% of Kenvue’s outstanding common stock was owned by Johnson & Johnson after the May 2023 IPO.[17]

Distribution channels in the consumer health industry

  • 10% was e-commerce’s year-on-year consumer health sales growth in 2025.[48]
  • 49.7% was Amazon’s share of U.S. consumer health purchase-intent clicks in Q2 2025.[65]
  • 81.4% was Meta’s share of U.S. consumer health shopper-traffic purchase-intent clicks in Q2 2025.[65]
  • 23% of consumer health sales occurred online in 2024.[48]
  • 74% of global consumer health sales came from offline retail in 2025.[48]

Key questions about the Consumer Health Industry

What is the global consumer health market size?
Global consumer health spending reached $337.9 billion in 2025, based on Euromonitor’s estimate.
How fast is consumer health expected to grow?
Heimdall Insights forecasts the global consumer healthcare market to grow from $345 billion in 2025 to $498 billion in 2030, a 7.6% CAGR.
Which companies lead the consumer health industry?
Procter & Gamble leads Gitnux's 2026 consumer health ranking with an Overall score of 9.4, with $12.456 billion in fiscal 2026 Health Care segment sales. STADA is the runner-up at 8.9, driven by €1.549 billion Consumer Healthcare segment sales in 2025.
Where are technology shifts showing up in consumer health?
E-commerce accounted for 23% of consumer health sales in 2025, and consumer online medical-information discovery was 84.1% via search engines in 2026.
How fragmented is the market structure in the Americas?
In the Americas in 2024, the five largest companies held 24.9% of value sales, with Haleon at 5.2%.
What part of consumer health sales is online in the U.S.?
Consumer health sales online were 23% in 2025, while U.S. consumer health sales were $107B in 2025.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Lukas Bauer. (2026, February 13). Consumer Health Industry Statistics. Gitnux. https://gitnux.org/consumer-health-industry-statistics
MLA
Lukas Bauer. "Consumer Health Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/consumer-health-industry-statistics.
Chicago
Lukas Bauer. 2026. "Consumer Health Industry Statistics." Gitnux. https://gitnux.org/consumer-health-industry-statistics.

Sources & references

78 sources cited across this report

  1. invoca.com
  2. formative.jmir.org
  3. oliverwymanforum.com
  4. mckinsey.com
  5. pwc.com
  6. healthit.gov
  7. deloitte.com
  8. business.adobe.com
  9. kpmg.com
  10. go.rackspace.com
  11. cetic.br
  12. nic.br
  13. stada.com
  14. iqvia.com
  15. carta.healthcare
  16. intersystems.com
  17. sec.gov
  18. financialfilings.com
  19. apnews.com
  20. bigmarker-production.s3.amazonaws.com
  21. circana.com
  22. hrotoday.com
  23. investor.jnj.com
  24. medicaleconomics.com
  25. haleon.com
  26. ihirepharmacy.com
  27. ajg.com
  28. mgma.com
  29. wfhresearch.com
  30. weforum.org
  31. pressganey.com
  32. england.nhs.uk
  33. getresponse.com
  34. emarketer.com
  35. m3-mi.com
  36. 5wpr.com
  37. yougov.com
  38. ipsos.com
  39. sermo.com
  40. brand-news.it
  41. pewresearch.org
  42. media.sproutsocial.com
  43. fda.gov
  44. tcs.com
  45. ir.prestigebrands.com
  46. nielseniq.com
  47. s206.q4cdn.com
  48. euromonitor.com
  49. cmocouncil.org
  50. crnusa.org
  51. rrd.com
  52. us.pg.com
  53. kenvue.com
  54. reckitt.com
  55. ache.org
  56. proofpoint.com
  57. ponemonsullivanreport.com
  58. kff.org
  59. hfmmagazine.com
  60. sophos.com
  61. alvarezandmarsal.com
  62. afepadi.org
  63. scribd.com
  64. time.com
  65. mikmak.com
  66. heimdallinsights.com
  67. globenewswire.com
  68. researchandmarkets.com
  69. marketresearch.com
  70. canary.us.pg.com
  71. 05.cdn.stada.com
  72. nestle.com
  73. opella.com
  74. bayer.com
  75. investor.churchdwight.com
  76. investor.kimberly-clark.com
  77. herbalife.com
  78. investor.perrigo.com